May Friday 26th, the date! Official ceremony and technical seminar on Bioinnovo IgY DNT, the first product of the first private-public company of Vetanco-INTA. Important lecturers and national authorities will attend our presentation of Bioinnovo, an R&D company that developed the first subunit vaccine for BVDV and a biological product based on potency determined titles for bovine Coronavirus, Rotavirus, E. coli and Salmonella.
